KR0149274B1 - Medicaments for the treatment of cerebral apoplexy - Google Patents

Medicaments for the treatment of cerebral apoplexy

Info

Publication number
KR0149274B1
KR0149274B1 KR1019970061361A KR19970061361A KR0149274B1 KR 0149274 B1 KR0149274 B1 KR 0149274B1 KR 1019970061361 A KR1019970061361 A KR 1019970061361A KR 19970061361 A KR19970061361 A KR 19970061361A KR 0149274 B1 KR0149274 B1 KR 0149274B1
Authority
KR
South Korea
Prior art keywords
medicaments
treatment
cerebral apoplexy
apoplexy
cerebral
Prior art date
Application number
KR1019970061361A
Other languages
Korean (ko)
Inventor
Joerg Wilhelm Traber
Gerhard-Wilhelm Bielenbery
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3831888A external-priority patent/DE3831888A1/en
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Application granted granted Critical
Publication of KR0149274B1 publication Critical patent/KR0149274B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
KR1019970061361A 1988-09-20 1997-11-20 Medicaments for the treatment of cerebral apoplexy KR0149274B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3831888A DE3831888A1 (en) 1988-09-20 1988-09-20 MEDICINES FOR TREATING APOPLEXIA CEREBRI
KR1019890013434A KR0135307B1 (en) 1988-09-20 1989-09-19 Medicaments for the treatment of cerebral apoplexy

Publications (1)

Publication Number Publication Date
KR0149274B1 true KR0149274B1 (en) 1998-10-15

Family

ID=25872381

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019970061359A KR0149275B1 (en) 1988-09-20 1997-11-20 Medicaments for the treatment of cerebral apoplexy
KR1019970061361A KR0149274B1 (en) 1988-09-20 1997-11-20 Medicaments for the treatment of cerebral apoplexy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019970061359A KR0149275B1 (en) 1988-09-20 1997-11-20 Medicaments for the treatment of cerebral apoplexy

Country Status (1)

Country Link
KR (2) KR0149275B1 (en)

Also Published As

Publication number Publication date
KR0149275B1 (en) 1998-10-15

Similar Documents

Publication Publication Date Title
GB2188234B (en) Therapeutic agents
SG61693G (en) Medicaments for the treatment of emesis
GB8719367D0 (en) Therapeutic compounds
EP0249873A3 (en) Therapeutic agent for skin ulcers
GB8725939D0 (en) Therapeutic compounds
GB2220352B (en) Medicaments for the treatment of emesis
GB8629568D0 (en) Therapeutic agent
GB2216414B (en) Medicaments for the treatment of emesis
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
KR0149274B1 (en) Medicaments for the treatment of cerebral apoplexy
GB8720219D0 (en) Therapeutic agent
GB8626296D0 (en) Therapeutic agents
GB8603447D0 (en) Therapeutic compounds
GB8724564D0 (en) Therapeutic compounds
EP0272929A3 (en) Enkephalinase for therapeutic use
EP0412938A3 (en) System for the treatment of contactlenses
IE883710L (en) Medicaments for the treatment of anxiety
GB8629663D0 (en) Therapeutic agents
GB8529885D0 (en) Therapeutic agent
IE863048L (en) Therapeutic agent
GB8604611D0 (en) Therapeutic agent
GR3003007T3 (en) Process for the treatment of alpha-calciumsulphate-hemihydrate
GB8703900D0 (en) Therapeutic agent
RO92740B1 (en) Medicinal composition for the treatment of otites
GB8809045D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050524

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee